We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Electrostatic Dissipative Feature Augments New Line of Ductless Fume Hoods

By LabMedica International staff writers
Posted on 13 Aug 2013
A new line of fume hoods that promises laboratory workers superior protection against buildup of toxic fumes has been combined with electrostatic dissipative features to prevent static buildup and discharge.

Aura ductless fume hoods manufactured by Mystaire Misonix (Creedmoor, NC, USA) are self-contained, filtered enclosures that remove hazardous fumes, vapors, and particles from virtually any laboratory application. More...
Unlike traditional fume hoods, there are no installation costs and no ductwork is needed. The new Aura ESD line of hoods adds an electrostatic dissipation feature to the state-of-the art Aura line.

Each Aura ductless fume hood has advanced safety monitoring and controls including the EverSafe II microprocessor safety controller, which monitors and adjusts fume hood face velocity to a user-preset value. EverSafe II maintains face velocity at the proper rate for containment of potentially toxic gases and vapors.

The US made Aura fume hoods, which are available in 72.6 centimeter, 106.68 centimeter, and 137.16-centimeter widths have been ASHRAE (American Society of Heating, Refrigerating and Air Conditioning Engineers) 110 tested and provide excellent containment from toxic fumes and vapors. The Filtrak positive filter sealing system installed in each Aura ductless hood is a cam-driven filter sealing system with a built-in filter position indicator and an alert that informs the user if the filtration bed is not properly sealed. The Filtrak system enables safe and easy filter maintenance and replacement.

Related Links:
Mystaire Misonix



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.